| Abstrakt: |
A study conducted by the Ministry of Health in Tanzania analyzed the genotypes of rotavirus between 2013 and 2018 during the implementation of the ROTARIX vaccine. The study found a significant decrease in rotavirus positivity during this period. The most prevalent genotype was G1P [8], but its prevalence decreased over time, while the G9P [4] genotype increased. The study concluded that the ROTARIX vaccine has provided protection against various wild-type rotavirus strains, but continuous surveillance is necessary. [Extracted from the article] |
